(Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 ...
This partnership is a perfect synergy of billing expertise and transformative technology. Together, we are building an ...
The company's new C-suite represents decades of experience transforming organizations across the health IT and RCM spectrum.
1. R1 RCM is acquiring revenue cycle management company Acclara from Renton, Wash.-based Providence for $675 million. At the closing of the deal — expected in early 2024 — Acclara and Providence will ...
Athenahealth has announced updates to its revenue cycle management (RCM) platform that are designed to streamline administrative processes and reduce workloads for physician practices. The ...
XiFin, Inc., a leader in revenue cycle management (RCM), including billing solutions enhanced with artificial intelligence ...
The revenue cycle management (RCM) systems that US healthcare organizations use to manage billing patients and collecting fees have become increasingly complex, creating opportunities for private ...
Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice completed their $8.9 billion acquisition of R1 RCM on Nov. 19. Joe Flanagan, CEO: Mr. Flanagan reassumed the role of CEO ...
The Cloudmed integration appears to be already paying dividends for R1 RCM as a growth accelerator. Projections are for 48% YoY adj. EBITDA growth in FY23. The company looks undervalued at 12.75x ...
RCM Technologies experienced vigorous growth during COVID-19, faced setbacks in late 2022 and early 2023, but began recovering in the second half of 2023. Despite rising revenues in the third quarter, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback